Evidence map›Paper›PMID 27045028›Full record

ReviewHypertension (Dallas, Tex. : 1979)2016

Role of Bile Acid-Regulated Nuclear Receptor FXR and G Protein-Coupled Receptor TGR5 in Regulation of Cardiorenal Syndrome (Cardiovascular Disease and Chronic Kidney Disease).

Moshe Levi

Open access · greenAbstract readReview
In one paragraph

Review in Hypertension (Dallas, Tex. : 1979), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Moshe LeviFrom the Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado AMC, Aurora. Moshe.Levi@ucdenver.edu.
University of Colorado Denver · US

Funding

Role of FXR in Renal Disease of Metabolic Syndrome and AgingR01AG026529 · NIA · UNIVERSITY OF COLORADO DENVER · PI LEVI, MOSHE · 2007 to 2011
$1.8M
Treatment of Kidney Disease in Diabetes and ObesityR01DK098336 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LEVI, MOSHE · 2013 to 2016
$1.3M
Role of FXR and TGR5 in Age Related Renal DiseasesR01AG049493 · NIA · UNIVERSITY OF COLORADO DENVER · PI LEVI, MOSHE · 2016 to 2018
$917k
NIA NIH HHS R01 AG026529NIA NIH HHS R01 AG049493NIDDK NIH HHS R01 DK098336
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardio-Renal SyndromeReceptors, Cytoplasmic and NuclearReceptors, G-Protein-CoupledAnimalsDiabetes MellitusDisease ProgressionHumansLipid MetabolismObesityPrognosisReceptor, Farnesoid X-ActivatedGPBAR1 protein, humanReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearReceptors, G-Protein-Coupled

Identifiers

PMID27045028
PMCPMC5291829
OpenAlexW2342171400

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.